Page last updated: 2024-08-23

daunorubicin and Acute Promyelocytic Leukemia

daunorubicin has been researched along with Acute Promyelocytic Leukemia in 195 studies

Research

Studies (195)

TimeframeStudies, this research(%)All Research%
pre-199011 (5.64)18.7374
1990's77 (39.49)18.2507
2000's55 (28.21)29.6817
2010's46 (23.59)24.3611
2020's6 (3.08)2.80

Authors

AuthorsStudies
Mao, Y; Tang, F; Xu, X; Zhu, X1
Aggarwal, M; Dass, J; Dhawan, R; Kumar, P; Mahapatra, M; Seth, T; Tyagi, S; Vaid, T; Viswanathan, GK1
Arao, Y; Fujimoto, K; Fukaya, K; Furusawa, K; Haga, T; Hiraiwa, H; Kano, N; Kato, H; Kondo, T; Kuwayama, T; Morimoto, R; Murohara, T; Mutsuga, M; Oishi, H; Okumura, T; Sawamura, A; Shimizu, S; Sugiura, Y; Usui, A; Watanabe, N; Yamaguchi, S; Yokoi, T1
Dong, M; Liu, Q; Nong, Q; Xie, R; Zhang, C1
Cangini, D; Cerchione, C; Ghelli Luserna Di Rorà, A; Giannini, MB; Gottardi, M; Martinelli, G; Padella, A; Simonetti, G; Sperotto, A1
DiNardo, CD; Kadia, TM; Kantarjian, HM; Ravandi, F; Welch, MA1
Gale, RE; Garbowski, M; Khwaja, A; Linch, DC; Loddo, M; Sellar, RS; Stoeber, K; Williams, GH1
Balasubramanian, P; Goni, D; Malhotra, P; Nampoothiri, RV1
Hou, JX; Li, HT; Liu, ZY; Wang, P; Yang, DG; Zhang, YM; Zhao, SY1
Feusner, JH; Geyer, S; Gregory, J; Kutny, MA; Larson, RA; Laumann, KM; Powell, BL; Stock, W; Willman, CL1
Afsar, NA; Kulsoom, B; Shamsi, TS1
Bruserud, O; Døskeland, SO; Gausdal, G; Gjertsen, BT; Havemann, U; Herfindal, L; Kleppe, R; Lanotte, M; McCormack, E; Nguyen, E; Pendino, F; Rouhee, N; Schwede, F; Ségal-Bendirdjian, E; Skavland, J; Wergeland, A1
Adès, L; Cassinat, B; Chevret, S; Chomienne, C; de Botton, S; Deconinck, E; Degos, L; Dombret, H; Fenaux, P; Ferrant, A; Guerci-Bresler, A; Huguet, F; Lambert, JF; Lamy, T; Lioure, B; Pigneux, A; Quesnel, B; Raffoux, E; Thomas, X; Vekhoff, A; Vey, N1
Duan, Y; Nie, J; Shang, W; Zhang, H; Zhang, Z; Zhou, L; Zhu, F; Zhu, H1
Creutzig, U; Dworzak, MN; Reinhardt, D; Ritter, J; Schellong, G; Zimmermann, M1
Bennett, D; Drago, MJ; Elder, D; Kim, BS; Rosenbach, M1
Chen, M; Liu, T; Niu, T; Wang, L; Xie, LP; Zeng, K; Zou, XL1
Huang, J; Jin, J; Lou, Y; Mai, W; Meng, H; Qian, W; Tong, H; Tong, Y1
Chen, L; He, Y; Li, X; You, Y; Zhang, M; Zheng, J; Zou, J; Zou, P1
Bailly, N; Chatelain, B; Chatelain, C; Devalet, B; Dogné, JM; Gheldof, D; Mullier, F1
Beyer, F; Franke, M; Persigehl, T; Theurich, S1
Miyawaki, S1
Su, Y; Zhang, L; Zhang, R; Zhou, X1
Aspillaga, A; Cabrera, ME; Palma, T; Puga, B; Rojas, B; Rossle, A; Undurraga, MS; Vergara, CG1
Altman, JK; Appelbaum, FR; Attar, EC; Coutre, SE; Gore, SD; Kopecky, KJ; Larson, RA; Levitan, D; Maher, T; Othus, M; Paietta, E; Powell, B; Stock, W; Tallman, MS; Wetzler, M; Willman, CL1
Chen, L; Gao, L; Hu, X; Lü, S; Song, X; Wang, J; Yang, J; Zhang, W1
Iacoboni, G; Montesinos, P; Sanz, MA1
Berliner, N; Bittencourt, R; Chauffaille, Mde L; Chiattone, CS; Fagundes, EM; Gallagher, R; Ganser, A; Grimwade, D; Jacomo, RH; Kim, HT; Kwaan, HC; Lima, AS; Lo-Coco, F; Löwenberg, B; Lucena-Araujo, AR; Martinez, L; Melo, RA; Niemeyer, CM; Pagnano, K; Pasquini, R; Rego, EM; Ribeiro, RC; Ruiz-Argüelles, G; Sanz, MA; Schrier, SL; Tallman, MS; Undurraga, MS1
Chen, RL; Huang, BT; Li, BS; Zeng, QC; Zhao, WH1
Gong, Y; Naren, D; Shi, F; Shi, R; Wu, J; Yang, X1
Berliner, N; Bittencourt, R; Brunet, S; De la Serna, J; De Lisa, E; Fagundes, EM; Fernández, P; Ganser, A; González-Campos, J; González-Huerta, AJ; Gutiérrez-Aguirre, H; Holowiecka, A; Jacomo, RH; Kim, HT; Krsnik, I; Lo-Coco, F; Löwenberg, B; Martínez, L; Melo, RA; Montesinos, P; Pagnano, K; Pasquini, R; Rego, EM; Ribeiro, RC; Ribera, JM; Ruiz-Argüelles, GJ; Sanz, MA; Undurraga, MS; Uriarte, MR; Vellenga, E1
Chen, X; Guo, S; Qin, N; Zhang, X1
Gong, BF; Gong, XY; Gu, RX; Li, W; Li, Y; Lin, D; Liu, BC; Liu, KQ; Liu, YT; Mi, YC; Wang, JX; Wang, JY; Wang, Y; Wei, H; Wei, SN; Zhang, GJ; Zhao, XL; Zhou, CL1
Ekpenyong, AE; Gross, E; Guck, J; Mimlitz, M; Nichols, M; Ning, J; Prathivadhi-Bhayankaram, SV; Taylor, C1
Adamcová, M; Gersl, V; Hasková, P; Hroch, M; Kaiserová, H; Ponka, P; Popelová, O; Simůnek, T; Sterba, M1
Chen, J; Dong, L; Gu, LJ; Jiang, H; Pan, C; Tang, JY; Wang, YP; Xue, HL; Ye, QD; Zhou, M1
Kassam, A; Mandel, K1
Altman, JK; Tallman, MS1
Haung, YK; Lin, PJ; Liu, KS; Tsai, FC; Wu, MY1
Betancourt-García, RD; Castro, J; Fernández, AC; Fradera, J; López-Enríquez, A; Pacheco, E1
Alonzo, T; Appelbaum, F; Feusner, J; Gerbing, R; Gregory, J; Kim, H; Rowe, J; Schiffer, C; Shepherd, L; Tallman, M; Weinstein, H; Wiernik, P; Willman, C; Woods, W1
Matsumura, I1
Ammar, F; Azghari, A; Bensaid, Y; Boayad, M; Boukhbrine, MK; Bouziane, Z; El Mesnaoui, A; Idrissi, R; Lekehal, B; Sefiani, Y; Tijani, Y1
Burnett, AK; Gale, RE; Gilkes, A; Goldstone, AH; Green, C; Guy, C; Hills, RK; Jenkinson, S; Koo, K; Linch, DC; Milligan, DW; Patel, Y; Prentice, AG; Wheatley, K1
Collins, C; Knoderer, H1
Arceci, R; Dauses, T; Devetten, M; Gallagher, RE; Gojo, I; Gore, SD; Jamieson, K; Morris, L; Owoeye, I; Redner, RL; Schachter-Tokarz, E; Sekeres, MA1
Dhall, G; Ettinger, LJ; Kurer, CC; Mahadeo, KM1
Cao, F; Gilbert, GE; Heegaard, CW; Hou, J; Rasmussen, JT; Shi, J; Zhang, Y; Zhou, J1
Tallman, MS1
Appelbaum, FR; Couban, S; Coutre, S; Feusner, JH; Gallagher, RE; Gregory, J; Larson, RA; Moser, B; Powell, BL; Rowe, JM; Stock, W; Stone, RM; Tallman, MS; Willman, CL1
Altman, J; Kuzel, T; Parajuli, R; Perdekamp, M; Tallman, M1
Appelbaum, FR; Bennett, JM; Bloomfield, CD; de la Serna, J; Deben, G; Feusner, JH; Gallagher, R; Gonzalez, J; Gonzalez, M; Kim, HT; Larson, RA; Miguel, JD; Milone, G; Montesinos, P; Paietta, E; Rayon, C; Rivas, C; Rowe, JM; Sanz, MA; Schiffer, CA; Shepherd, L; Slack, JL; Tallman, MS; Vellenga, E; Wiernik, PH; Willman, CL1
Chen, X; Chen, Y; Zhang, L; Zhu, X; Zou, Y1
Hasegawa, E; Hayami, N; Hiramatsu, R; Hoshino, J; Marui, Y; Sawa, N; Sumida, K; Suwabe, T; Takaichi, K; Takemoto, F; Tsuchiya, Y; Ubara, Y; Yamanouchi, M1
Au, WY; Kumana, CR; Kwong, YL; Lau, JS; Lee, HK; Lin, SY; Liu, H; Yeung, DY1
Gurung, A; Huang, BT; Li, BS; Xiao, Z; Zeng, QC; Zhao, WH1
Chen, Y; Li, Z; Lu, Q1
Bittencourt, R; Chauffaille, Mde L; Chiattone, C; Fagundes, EM; Gallagher, R; Garcés-Eisele, J; Gómez-Almaguer, D; Gutiérrez-Aguirre, H; Jacomo, RH; Kim, HT; Kwaan, H; LoCoco, F; Lowenberg, B; Martinez, L; Meillón, LA; Melo, RA; Niemeyer, CM; Pagnano, K; Pasquini, R; Rego, EM; Ribeiro, R; Ruiz-Argüelles, GJ; Sanz, MA; Uriarte, Mdel R1
Cao, FL; Gao, CY; Hou, JX; Li, JM; Li, JN; Liu, SC; Liu, Y; Ma, RS; Shi, JL; Tan, XY; Wang, J; Yang, X; Zhou, J1
Aul, C; Berdel, WE; Braess, J; Büchner, T; Erben, P; Haferlach, C; Haferlach, T; Hanfstein, B; Hehlmann, R; Heinecke, A; Hiddemann, W; Hofmann, WK; Horst, HA; Kreuzer, KA; Krug, U; Lengfelder, E; Müller-Tidow, C; Sauerland, C; Schneider, S; Schnittger, S; Schultheis, B; Serve, H; Spiekermann, K; Wörmann, B1
Nabhan, C; Tallman, MS1
Demidova, IA; Isaev, VG; Ol'shanskaia, IuV; Parovichnikova, EN; Savchenko, VG; Shuravina, EN1
Bogdanovic, A; Colovic, M; Colovic, N; Jankovic, G; Miljic, P1
Andersen, JW; Appelbaum, FR; Bloomfield, CD; Feusner, JH; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Weinstein, H; Wiernik, PH; Willman, C; Woods, WG1
Higashihara, M; Honma, Y; Niitsu, N1
Itoh, M; Shimada, H; Takao, S; Yago, K1
Goede, A; Kalk, E; Rose, P1
Fujisawa, S; Fujita, H; Hyo, R; Ishigatsubo, Y; Kanamori, H; Koharazawa, H; Takemura, S; Tanaka, M1
Damon, L; Demirer, T; Derigs, G; Ferrante, P; Kröger, N; Rosti, G; Wandt, H; Zander, AR1
Kondo, T; Mikami, M; Nakanishi, H; Otsuki, T; Suemori, S; Suetsugu, Y; Sugihara, T; Tsujioka, T; Wada, H; Yamamori, S1
Baruchel, A; Bordessoule, D; Chevret, S; Chomienne, C; Coiteux, V; Conde, E; de Botton, S; de La Serna, J; Degos, L; Fegueux, N; Fenaux, P; Fey, M; Leverger, G; Parry, A; Philippe, N; Rayon, C; Robert, A; San Miguel, J; Sanz, M; Sotto, JJ; Vilmer, E1
Iguchi, A; Kobayashi, K; Kobayashi, R; Nakajima, M; Sato, T1
Baker, RJ; Burgess, M; Ethell, M; Ganeshaguru, K; Gerrard, G; Jones, DT; McCullough, H; Mehta, AB; Payne, E; Potter, M; Prentice, HG1
Aleksanian, MZh; Anchukova, LV; Demidova, IA; Domracheva, EV; Filatov, LB; Gribanova, EO; Isaev, VG; Kaplanov, K; Khoroshko, ND; Konstantinova, TS; Kravchenko, SK; Lapin, VA; Mashuk, VN; Miliutina, GI; Misiurin, AV; Ol'shanskaia, IuV; Parovichnikova, EN; Perekatova, TN; Pristupa, AS; Rekhtman, GB; Savchenko, VG; Shuravina, EN; Sokolova, I; Sviridova, EI; Ustinova, EN; Volkova, SA; Zagoskina, TP; Ziuzgin, IS1
Chandy, M; George, B; Poonkuzhali, B; Srivastava, A; Srivastava, VM1
Bayraktaroglu, T; Borazan, A; Demircan, N; Ozdemir, H; Ozer, T; Savranlar, A; Ustündag, Y1
Furukawa, H; Iguchi, A; Kobayashi, K; Kobayashi, R; Koizumi, S; Nakajima, M; Sato, T; Todoh, S1
Buerger, AU; Fey, MF; Garamvoelgyi, EM; Mueller, BU; Oppliger-Leibundgut, E; Pabst, T; Solenthaler, M1
Duvvuri, M; Funk, RS; Konkar, S; Krise, JM; Krise, JP1
Forrest, DL; Hogge, DE; Lavoie, JC; Nantel, SH; Nevil, TJ; Savoie, ML; Shepherd, JD; Smith, CA; Song, KW; Sutherland, HJ; Toze, CL1
Csík, G; Hudecz, F; Kovács, P; Reig, F; Reményi, J1
Dubrulle, S; Faussat, AM; Legrand, O; Majdak, P; Marie, JP; Marjanovic, Z; Marzac, C; Tang, R1
Baer, MR; Barcos, M; Finlay, E; Pawarode, A; Sait, SN1
Brandalise, SR; Matsuda, EI; Nowill, AE; Oliveira, SN; Rodrigues, PC; Viana, MB; Yunes, JA1
Adès, L; Chevret, S; Chomienne, C; de Botton, S; Deconinck, E; Degos, L; Dombret, H; Fegueux, N; Fenaux, P; Ferrant, A; Guerci, A; Lamy, T; Maloisel, F; Meyer-Monard, S; Pigneux, A; Raffoux, E; Rigal-Huguet, F; Stoppa, AM; Thomas, X; Vekhoff, A1
Cassinat, B; Chomienne, C; Fenaux, P; Guillemot, I; Moluçon-Chabrot, C; Tournilhac, O; Zassadowski, F1
Barnett, MJ; Bruyere, H; Dalal, BI1
Chaubey, R; Dutta, P; Hasan, SK; Kumar, B; Kumar, R; Pillai, LS; Saxena, R; Sazawal, S1
Fadilah, SA; Leong, CF; Raja-Zahratul-Azma, RS1
Chen, FY; Luo, ZG; Ouyang, RR; Wang, HR; Zhong, L1
Ahmed, Z; Byrd, RP; Mehta, JB; Raval, A; Roy, TM; Shaikh, MA1
Li, D; Wei, F; Zhang, W; Zhang, X1
Arai, M; Hamasai, K; Hirai, H; Matsuya, S; Mimura, T; Morino, N; Nakamoto, T; Nojima, Y; Yazaki, Y1
Bassini, A; Celeghini, C; Gibellini, D; Manfroi, S; Ottaviani, E; Pagliarini, C; Tosi, P; Tura, S; Visani, G; Zauli, G1
Anzai, S; Fujimaki, K; Fujisawa, S; Fukawa, H; Hattori, M; Motomura, S; Okubo, T1
Efferth, T; Fabry, U; Glatte, P; Osieka, R1
Arima, N; Hidaka, S; Matsumoto, T; Matsushita, K; Ohtsubo, H; Tanaka, H1
Gunning, K; Harman, K; Mahendra, P; Marcus, RE; Phillips, M1
Bauduer, F; Cymbalista, F; Delmer, A; Fenaux, P; Marie, JP; Martin, A; Rio, B; Zittoun, R1
Archim-Baud, E; Castaigne, S; Chastang, C; Chomienne, C; Degos, L; Fenaux, P; Fey, M; Link, H; Löwenberg, B; Sanz, M1
Fenaux, P1
Bernard, J1
Asou, N; Kanamaru, A; Kobayashi, T; Kuriyama, K; Murakami, H; Ohmoto, E; Sakamaki, H; Takemoto, Y; Tanimoto, M; Tsubaki, K1
Cenacchi, A; Gamberi, B; Manfroi, S; Ottaviani, E; Tosi, P; Tura, S; Visani, G1
Caron, PC; Finn, RD; Jurcic, JG; Larson, SM; Maslak, P; Miller, WH; Scheinberg, DA; Warrell, RP; Yao, TJ1
Beck, J; Gekeler, V; Ise, W; Sanders, KH; Ulrich, WR1
Chastang, C; Chomienne, C; Degos, L; Fenaux, P1
Andreeff, M; Godfrey, L; Hegewisch-Becker, S; Maslak, P1
Corey, SJ; Gollin, SM; Locker, J; Oliveri, DR; Penchansky, L; Redner, RL; Shekhter-Levin, S1
Faussat-Suberville, AM; Maisonneuve, L; Marie, JP; Zhou, DC; Zittoun, R1
Ikeda, Y; Iki, S; Ohbayashi, Y; Urabe, A; Yoshinaga, K1
Batlle, J; López Fernández, MF; Rodríguez Gómez, M1
Eardley, AM; Heller, G; Warrell, RP1
Haas, OA; Kapiotis, S; Knöbl, P; Korninger, L; Kyrle, PA; Laczika, K; Mitterbauer, G; Oehler, L; Pont, J; Schwarzinger, I1
Gassmann, W; Glass, B; Haferlach, T; Löffler, H1
Ikeda, K; Kubota, Y; Murata, M; Nagai, M; Ohnishi, H; Sasaki, K; Takahara, J; Tanaka, T; Taoka, T; Tasaka, T1
Ohno, R1
Becher, R; Fonatsch, C; Gassmann, W; Haase, D; Haferlach, T; Jürgensen, C; Löffler, H; Ludwig, WD; Noak, J; Thiel, E1
Arborio, M; De Revel, T; Desangles, F; Flandrin, G; Vilain, E1
Hoffman, MA; Kleiner, GJ; Wiernik, PH1
Estey, EH; Freireich, EJ; Ghaddar, HM; Kantarjian, HM; Keating, MJ; Pierce, S1
Asou, H; Awaya, N; Ikeda, Y; Kamada, N; Kawai, Y; Kizaki, M; Matsushita, H; Muto, A; Takayama, N; Ueno, H1
Gonzalez-Gonzalez, A; Pinilla, J; Requena, A; Velasco, JG1
Chomienne, C; Degos, L; Fenaux, P1
Chan, CH; Chan, LC; Chan, TK; Chim, CS; Chu, YC; Kwong, YL; Liang, R; Wong, KF1
Appelbaum, FR; Chen, IM; Godwin, J; Head, DR; Kopecky, KJ; Leith, CP; McConnell, T; Slovak, ML; Willman, CL1
Arthur, DC; Bigner, S; Bloomfield, CD; Carroll, AJ; Davey, FR; Lawrence, D; Mayer, RJ; Mrózek, K; Pettenati, MJ; Rao, KW; Schiffer, CA; Slack, JL; Tantravahi, R1
Kurtz, JE; Maloisel, F; Oberling, F1
Ohnishi, K; Ohno, R; Shinjyo, K; Takeshita, A; Tobita, T; Yanagi, M1
Hiraoka, A; Karasuno, T; Kitamura, K; Miyawaki, S; Naoe, T; Ohnishi, K; Ohno, R; Takeshita, A; Takeuchi, M; Tobita, T; Ueda, R; Yanagi, M1
Harano, H; Kanamori, H; Matsuzaki, M; Mohri, H; Ogawa, K; Okubo, C; Okubo, T; Otsuka, M; Sasaki, S; Taguchi, J1
Andersen, JW; Appelbaum, FR; Bloomfield, CD; Feusner, JH; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Wiernik, PH; Willman, C1
Babić, D; Bila, JS; Colović, MD; Elezović, I; Janković, GM; Novak, A; Vidović, A1
Honma, Y; Kanatani, Y; Matsuda, A; Niitsu, N; Shuto, S; Umeda, M; Yamamoto-Yamaguchi, Y1
Asami, K; Eguchi, H; Fujimoto, T; Gushiken, T; Hirota, T; Hyakuna, N; Imaizumi, M; Kamitamari, A; Katano, N; Kawakami, K; Koizumi, S; Komatu, K; Miyake, M; Mugishima, H; Nakadate, N; Nishikawa, K; Shirahata, A; Takitani, K; Tsurasawa, M; Yanase, T1
Adachi, K; Akiyama, H; Asou, N; Emi, N; Hiraoka, A; Kageyama, S; Kanamaru, A; Kitano, K; Kuriyama, K; Matsuda, S; Miyawaki, S; Nishikawa, K; Oh, H; Ohno, R; Ohtake, S; Omoto, E; Saito, K; Suzushima, H; Takahashi, M; Takeyama, K; Tamura, J; Tsubaki, K; Yamada, O1
Qiau, Z; Wang, C; Yang, L1
Carrera, I; Ding, W; Gallagher, RE; Grills, G; Li, YP; Nobile, LM; Paietta, E; Tallman, MS; Wiernik, PH1
Archimbaud, E; Fiere, D; Thomas, X1
Biondi, A; Coppi, MR; Liso, V; Mestice, A; Mininni, D; Palumbo, G; Pogliani, EM; Rossi, V; Specchia, G; Teruzzi, E1
Bernasconi, C; Castagnola, C; Corso, A; Dabusti, M; Lazzarino, M; Lunghi, M; Tajana, M; Zappasodi, P1
Harada, M; Kibata, M; Ohno, R; Omoto, E; Shudo, K; Takahashi, K; Takeuchi, M; Ueda, R; Yano, T1
Advani, SH; Bapna, A; Gladstone, B; Gopal, R; Kadam, P; Nair, CN; Nair, R; Parekh, PM; Saikia, TK1
Janckila, A; Varghese, L; Yam, LT1
Mollee, PN; Rodwell, R; Taylor, D; Taylor, KM; Williams, B1
Caen, J; Cai, X; Chen, GQ; Chen, SJ; Chen, Z; Guo, WM; Ju, B; Pan, L; Sun, GL; Wang, HL; Wang, ZY; Yao, YY; Zhao, WL; Zhu, J1
Medvedev, PV; Moiseeva, TN; Pivnik, AV; Shklovskiĭ-Kordi, NE; Shtroiakovskiĭ, DL; Skorokhod, AA1
Demidova, IA; Galstian, GM; Isaev, VG; Kliasova, GA; Ol'shanskaia, IuV; Parovichnikova, EN; Pivnik, AV; Savchenko, VG; Tikhonova, LIu; Tiurina, NG1
Iwata, N; Kawahigashi, N; Kobayashi, Y; Maeda, A; Saito, T; Takaue, Y; Takenaka, T; Tanosaki, R; Tobinai, K; Togitani, K1
Andersen, JW; Appelbaum, FR; Feusner, JH; François, C; Larson, RS; Ogden, A; Rowe, JM; Schiffer, CA; Shepherd, L; Tallman, MS; Wiernik, PH1
Ataullakhanov, FI; Garmaeva, TTs; Isaev, VG; Kucher, RA; Parovichnikova, EN; Savchenko, VG; Skorokhod, AA; Tiurina, NG; Vitvitskiĭ, VM1
Andersen, JW; Bloomfield, CD; Gallagher, RE; Li, YP; Slack, JL; Tallman, MS; Viswanatha, DS; Willman, CL1
Clark, M; Gieseler, F; Puschmann, M; Stiebeling, K; Valsamas, S1
Baccarani, M; Damiani, D; Ermacora, A; Geromin, A; Masolini, P; Michelutti, A; Michieli, M1
Boros, B; Egyed, M; Földi, J; Páldi-Haris, P; Rumi, G1
Catani, L; Grafone, T; Gugliotta, L; Isidori, A; Martinelli, G; Nocentini, F; Ottaviani, E; Pastano, R; Piccaluga, P; Testoni, N; Tosi, P; Tura, S; Vianelli, N; Visani, G1
Avigdor, A; Ben-Bassat, I; Bercowicz, M; Berkenstat, H; Levi, I; Perel, A; Raanani, P; Segal, E1
Abhyankar, D; Advani, S; Kapoor, B; Menon, H; Nair, R1
Bordessoule, D; Castaigne, S; Chevret, S; Chomienne, C; Cony Makhoul , P; De Botton , S; Deconinck, E; Degos, L; Desablens, B; Dombret, H; Fegueux, N; Fenaux, P; Fey, M; Gardin, C; Geiser, K; Guerci, A; Hess, U; Huguet, F; Link, H; Maloisel, F; Preudhomme, C; Rayon, C; San Miguel , J; Sanz, M; Solary, E; Sotto, JJ; Stamatoullas, A; Thomas, X; Travade, P1
Cabrera, ME; Ducach, G; Etcheverry, R; Puga, BL; Toledo, H; Undurraga, MS; Vacarezza, R1
Goh, YT; Koh, LP; Tan, P; Teoh, G1
Guo, W; Wang, H; Zhu, J1
Basu, S; Chachlani, N; Kalk, E; Rose, P1
Dabadghao, S; Melinkeri, SR; Mishra, SK1
Cayado, N; Gramatges, A; Hernández, P; Losada, R; Machín, S; Martinez, G1
Ballard, ET; Huang, FS; Stern, LE; Warner, BW; Zwerdling, T1
Mitchell, DC; Win, N1
Ashihara, E; Fujita, N; Gotoh, H; Inaba, T; Itoh, K; Murakami, S; Nishio, A; Ohkawa, K; Oku, N; Shimazaki, C1
Gardner, P; Gollapudi, S; Gupta, S; Kang, N; McDonald, T1
Archimbaud, E; Castaigne, S; Dombret, H; Duarte, M; Fenaux, P; Guerci, A; Lamy, T; Maloisel, F; Morel, P; Tilly, H1
Belloc, F; Bernard, P; Boisseau, MR; Dumain, P; Lacombe, F; Lopez, F; Reifers, J1
Abe, Y; Goto, T; Katsuno, M; Miyoshi, T; Muta, K; Nishimura, J; Sadamura, S; Taguchi, F; Takatsuki, H; Umemura, T1
Akiyoshi, T; Hisano, S; Ishibashi, M; Kimura, N; Morioka, E; Okumura, M; Suzumiya, J; Uchida, T1
Elliott, S; Marlton, P; Meagher, D; Rodwell, R; Taylor, D; Taylor, K; Timms, P; White, S; Wiley, J; Wright, S1
Center, MS; Marquardt, D1
Azuno, Y; Hiroshige, Y; Nishimura, M; Nishimura, Y; Okafuji, K; Seguchi, M; Tanaka, H; Tanaka, M; Ueda, K; Yoshida, T1
Hui, EK; Luo, KJ; Yung, BY1
Kaufmann, SH1
Cuddy, DP; de Valeriola, DL; Egorin, MJ; Forrest, A; Ross, DD1
Alegre, A; Algora, M; García Plaza, I; Llanos, ML; Lozano, M; Padilla, B; Peñalver, MA; Pérez-Pons, C1
Bordessoule, D; Castaigne, S; Colombat, P; Fenaux, P; Guy, H; Le Gall, E; Leblay, R; Leverger, G; Tertian, G; Tilly, H1
Costello, C; McCarthy, D; Mir, N; Nadir, F; Rule, S; Samson, D; Taylor, J1
DeRosa, WT; Hait, WN1
Monti, E; Sinha, BK1
Avvisati, G; Lamping, R; Mandelli, F; Petti, MG; Sturk, A; ten Cate, JW1
Benstead, TJ; Hayne, OA; McCormick, CW; Nevill, TJ1
Chubachi, A; Endo, Y; Miura, AB; Nishimura, S1
Akahoshi, Y; Asou, N; Fujimoto, K; Fukuda, S; Ishimaru, S; Kawano, F; Murai, C; Sawatari, T; Taen, A; Takatsuki, K1
Maruyama, Y; Nagata, K; Nakamura, S; Onozawa, Y; Sakamaki, H; Yahara, Y1
Fukutani, H; Hirano, A; Horikoshi, N; Inoue, K; Itami, S; Mizunuma, N; Mukaiyama, T; Ogawa, M; Tabata, M1
Imoto, S; Ito, M; Nakagawa, T; Okamura, A; Saito, S; Taomoto, K; Yamada, H1
Mandelli, F; Petti, MC1
Clarkson, BD; Cunningham, I; Gee, TS; Kempin, SJ; Naval, AN; Reich, LM1
Burres, NS; Myers, MT; Sartorelli, AC1
Cohen, A; Estrov, Z; Freedman, MH; Gelfand, EW1

Reviews

19 review(s) available for daunorubicin and Acute Promyelocytic Leukemia

ArticleYear
Gemtuzumab ozogamicin in acute myeloid leukemia: past, present and future.
    Minerva medica, 2020, Volume: 111, Issue:5

    Topics: Aged; Animals; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Calicheamicins; Chlorides; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Approval; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Mice; Middle Aged; Multicenter Studies as Topic; Recurrence; Sialic Acid Binding Ig-like Lectin 3; Tretinoin

2020
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach.
    Cancer, 2021, 04-15, Volume: 127, Issue:8

    Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Bridged Bicyclo Compounds, Heterocyclic; Cladribine; Core Binding Factors; Cytarabine; Daunorubicin; Gemtuzumab; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mutation; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasm, Residual; Sulfonamides; Survival Rate; Translational Research, Biomedical; Tretinoin; Vidarabine

2021
Development of a curative treatment within the AML-BFM studies.
    Klinische Padiatrie, 2013, Volume: 225 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Germany; Humans; Idarubicin; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Methotrexate; Multicenter Studies as Topic; Prednisone; Randomized Controlled Trials as Topic; Survival Rate; Thioguanine; Vincristine

2013
[Current therapy for acute myeloid leukemia and acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Drug Discovery; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Molecular Targeted Therapy; Mutation; Recurrence; Tretinoin; Vincristine

2014
[Report of a case with secondary acute promyelocytic leukemia after therapy for hemophagocytic lymphohistiocytosis and review of literature].
    Zhonghua er ke za zhi = Chinese journal of pediatrics, 2013, Volume: 51, Issue:12

    Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Daunorubicin; Epstein-Barr Virus Infections; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lymphohistiocytosis, Hemophagocytic; Male; Neoplasms, Second Primary; Risk Assessment; Treatment Outcome; Tretinoin

2013
Conventional induction and post-remission therapy in APL: have we arrived?
    Best practice & research. Clinical haematology, 2014, Volume: 27, Issue:1

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Consolidation Chemotherapy; Daunorubicin; Harringtonines; Homoharringtonine; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Mercaptopurine; Methotrexate; Mitoxantrone; Multicenter Studies as Topic; Oxides; Remission Induction; Tretinoin

2014
Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Puerto Rico health sciences journal, 2009, Volume: 28, Issue:2

    Topics: Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Drug Synergism; Fatal Outcome; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Mitoxantrone; Monosomy; Neoplasms, Second Primary; Translocation, Genetic; Tretinoin

2009
[Standard therapies for acute myeloid leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2009, Volume: 50, Issue:10

    Topics: Aminoglycosides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenites; Cytarabine; Daunorubicin; Gemtuzumab; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Remission Induction

2009
[Acute lower limb ischemia revealing acute leukemia. Case report and review of the literature].
    Journal des maladies vasculaires, 2010, Volume: 35, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cytarabine; Daunorubicin; Emergencies; Femoral Artery; Humans; Ischemia; Leg; Leukemia, Promyelocytic, Acute; Leukostasis; Male; Popliteal Artery; Remission Induction; Thrombectomy; Tretinoin

2010
Management of acute promyelocytic leukemia.
    Current oncology reports, 2002, Volume: 4, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Daunorubicin; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Promyelocytic, Acute; Oxides; Remission Induction; Tretinoin

2002
Central nervous system relapse in acute promyelocytic leukemia.
    American journal of hematology, 2002, Volume: 71, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Male; Methotrexate; Tretinoin

2002
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Bone marrow transplantation, 2003, Volume: 32, Issue:12

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Epirubicin; Female; Humans; Incidence; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukemia, Radiation-Induced; Lymphatic Metastasis; Melphalan; Middle Aged; Mitoxantrone; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Radiotherapy, Adjuvant; Thiotepa; Transplantation Conditioning; Transplantation, Autologous

2003
[Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2004, Volume: 45, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Liver Transplantation; Living Donors; Ornithine Carbamoyltransferase Deficiency Disease; Remission Induction; Tacrolimus; Tretinoin

2004
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
    Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Differentiation; China; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Europe; Humans; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocytosis; Life Tables; Middle Aged; Mitoxantrone; New York; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin

1995
Acute promyelocytic leukemia and pregnancy. A case report.
    Cancer, 1995, Dec-01, Volume: 76, Issue:11

    Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Female; Fetal Death; Humans; Leukemia, Promyelocytic, Acute; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Second; Prenatal Care; Remission Induction; Tretinoin

1995
Acute promyelocytic leukemia: biology and treatment.
    Seminars in oncology, 1997, Volume: 24, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Neoplasm, Residual; Recurrence; Translocation, Genetic; Tretinoin

1997
Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
    Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Benzoates; Biomarkers, Tumor; Cheilitis; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Pilot Projects; Recurrence; Remission Induction; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin; Tumor Cells, Cultured

1998
Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    The Journal of the Kentucky Medical Association, 1999, Volume: 97, Issue:2

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Male; Translocation, Genetic; Tretinoin

1999
[Chronic myelocytic leukemia following chemotherapy of acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11

    Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisolone; Remission Induction

1989

Trials

50 trial(s) available for daunorubicin and Acute Promyelocytic Leukemia

ArticleYear
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance).
    Pediatric blood & cancer, 2019, Volume: 66, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Prognosis; Survival Rate; Tretinoin

2019
Lung resistance-related protein (LRP) predicts favorable therapeutic outcome in Acute Myeloid Leukemia.
    Scientific reports, 2019, 01-23, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Bone Marrow; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Vault Ribonucleoprotein Particles

2019
Long-term follow-up of European APL 2000 trial, evaluating the role of cytarabine combined with ATRA and Daunorubicin in the treatment of nonelderly APL patients.
    American journal of hematology, 2013, Volume: 88, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Risk Factors; Treatment Outcome; Tretinoin

2013
Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy.
    British journal of haematology, 2014, Volume: 165, Issue:4

    Topics: Adult; Aged; Aminoglycosides; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Dogs; Female; Gemtuzumab; Humans; Leukemia, Promyelocytic, Acute; Maintenance Chemotherapy; Male; Mercaptopurine; Methotrexate; Middle Aged; Oncogene Proteins, Fusion; Oxides; Platelet Count; Remission Induction; Risk; Treatment Outcome; Tretinoin; Young Adult

2014
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies.
    Annals of hematology, 2015, Volume: 94, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Disease-Free Survival; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Matched-Pair Analysis; Middle Aged; Risk Factors; Treatment Outcome; Tretinoin; Young Adult

2015
[Homoharringtonine in newly diagnosed acute promyelocytic leukemia treatment: a prospective, randomized controlled trial].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2016, Volume: 37, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Daunorubicin; Disease-Free Survival; Harringtonines; Homoharringtonine; Humans; Incidence; Leukemia, Promyelocytic, Acute; Leukocyte Count; Neoadjuvant Therapy; Platelet Transfusion; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin

2016
Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.
    Pediatric blood & cancer, 2009, Volume: 53, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin

2009
The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and C
    Blood, 2010, Feb-04, Volume: 115, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Proteins; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Genotype; Humans; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin; Reverse Transcriptase Polymerase Chain Reaction; Thioguanine; Treatment Outcome; Tretinoin; Young Adult

2010
Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Feb-20, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Oxides; Prognosis; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young Adult

2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.
    Blood, 2010, Nov-11, Volume: 116, Issue:19

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; North America; Oxides; Survival Analysis; Treatment Outcome; Tretinoin; Young Adult

2010
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
    Blood, 2010, Dec-16, Volume: 116, Issue:25

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin; Young Adult

2010
Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study.
    Blood, 2011, Dec-15, Volume: 118, Issue:25

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Cytarabine; Daunorubicin; Disease-Free Survival; Dyspepsia; Female; Follow-Up Studies; Headache; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Tretinoin

2011
The early addition of arsenic trioxide versus high-dose arabinoside is more effective and safe as consolidation chemotherapy for risk-tailored patients with acute promyelocytic leukemia: multicenter experience.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Tretinoin; Young Adult

2012
[Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].
    Terapevticheskii arkhiv, 2002, Volume: 74, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Daunorubicin; Drug Therapy, Combination; Female; Humans; Interferon-alpha; Leukemia, Promyelocytic, Acute; Liposomes; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Pilot Projects; Polymerase Chain Reaction; Remission Induction; Tretinoin

2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.
    Blood, 2002, Dec-15, Volume: 100, Issue:13

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Infant; Leukemia, Promyelocytic, Acute; Leukocyte Count; Life Tables; Male; Middle Aged; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Tretinoin

2002
Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Apr-15, Volume: 22, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Treatment Outcome; Tretinoin

2004
Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.
    Haematologica, 2004, Volume: 89, Issue:7

    Topics: Abdominal Pain; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytarabine; Daunorubicin; Diarrhea; Dibenzocycloheptenes; Drug Resistance; Drug Screening Assays, Antitumor; Female; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nausea; Quinolines; Remission Induction

2004
[Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].
    Terapevticheskii arkhiv, 2004, Volume: 76, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcr; Remission Induction; Transcription, Genetic; Tretinoin

2004
Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-20, Volume: 24, Issue:36

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Analysis; Tretinoin

2006
Treatment of newly diagnosed acute promyelocytic leukemia (APL) by all transretinoic acid (ATRA) combined with chemotherapy: The European experience. European APL Group.
    Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cell Differentiation; China; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Europe; Humans; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocytosis; Life Tables; Middle Aged; Mitoxantrone; New York; Pilot Projects; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin

1995
Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
    Leukemia, 1994, Volume: 8 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Europe; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Mercaptopurine; Methotrexate; Recurrence; Remission Induction; Treatment Outcome; Tretinoin

1994
All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.
    Blood, 1995, Mar-01, Volume: 85, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Immunologic Factors; Japan; Leukemia, Promyelocytic, Acute; Leukocytosis; Life Tables; Male; Mercaptopurine; Middle Aged; Prednisolone; Prospective Studies; Remission Induction; Syndrome; Treatment Outcome; Tretinoin

1995
Pre-treatment with all-trans retinoic acid accelerates polymorphonuclear recovery after chemotherapy in patients with acute promyelocytic leukemia.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Hematopoiesis; Humans; Idarubicin; Immunologic Factors; Leukemia, Promyelocytic, Acute; Leukocyte Count; Leukocytosis; Male; Middle Aged; Neutrophils; Platelet Count; Premedication; Remission Induction; Salvage Therapy; Treatment Outcome; Tretinoin

1994
Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL Group.
    Lancet (London, England), 1994, Apr-23, Volume: 343, Issue:8904

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Tretinoin

1994
Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia.
    Leukemia, 1994, Volume: 8, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Daunorubicin; Drug Therapy; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Time Factors; Tretinoin

1994
Rapid achievement of PML-RAR alpha polymerase chain reaction (PCR)-negativity by combined treatment with all-trans-retinoic acid and chemotherapy in acute promyelocytic leukemia: a pilot study.
    Leukemia, 1994, Volume: 8, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Chromosomes, Human, Pair 15; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Molecular Sequence Data; Pilot Projects; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Sensitivity and Specificity; Tretinoin

1994
[Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2

    Topics: Administration, Oral; Chromosome Aberrations; Daunorubicin; Disseminated Intravascular Coagulation; Humans; Leukemia, Promyelocytic, Acute; Prospective Studies; Remission Induction; Tretinoin

1993
Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.
    Annals of hematology, 1993, Volume: 66, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cytarabine; Daunorubicin; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Thioguanine

1993
Amsacrine and continuous-infusion high-dose cytosine arabinoside as induction therapy for patients with newly-diagnosed acute myelogenous leukemia.
    Leukemia & lymphoma, 1996, Volume: 22, Issue:1-2

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Life Tables; Male; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine

1996
All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
    Hematological oncology, 1996, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Life Tables; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Prospective Studies; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Tretinoin

1996
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
    Blood, 1997, May-01, Volume: 89, Issue:9

    Topics: Age Factors; Aged; Aged, 80 and over; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Double-Blind Method; Drug Resistance, Multiple; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recombinant Proteins

1997
Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid.
    Blood, 1997, Aug-01, Volume: 90, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cell Differentiation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; Gastrointestinal Diseases; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Pain; Prospective Studies; Receptors, Retinoic Acid; Recurrence; Remission Induction; Retinoic Acid Receptor gamma; Retinoids; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin

1997
All-trans-retinoic acid in acute promyelocytic leukemia.
    The New England journal of medicine, 1997, Oct-09, Volume: 337, Issue:15

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Rate; Treatment Failure; Tretinoin

1997
Effect of all-trans-retinoic acid alone or in combination with chemotherapy in newly diagnosed acute promyelocytic leukaemia.
    Medical oncology (Northwood, London, England), 1997, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin

1997
[Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:11

    Topics: Aclarubicin; Administration, Oral; Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Prednisolone; Tretinoin; Vincristine

1997
Leukemic cellular retinoic acid resistance and missense mutations in the PML-RARalpha fusion gene after relapse of acute promyelocytic leukemia from treatment with all-trans retinoic acid and intensive chemotherapy.
    Blood, 1998, Aug-15, Volume: 92, Issue:4

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Daunorubicin; DNA Mutational Analysis; DNA, Neoplasm; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Point Mutation; Remission Induction; Tretinoin; Tumor Cells, Cultured

1998
Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
    Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Benzoates; Biomarkers, Tumor; Cheilitis; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Pilot Projects; Recurrence; Remission Induction; Salvage Therapy; Tetrahydronaphthalenes; Treatment Outcome; Tretinoin; Tumor Cells, Cultured

1998
Acute promyelocytic leukemia: all-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone.
    American journal of hematology, 1999, Volume: 60, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Child; Cytarabine; Daunorubicin; Female; Fever; Humans; Leukemia, Promyelocytic, Acute; Lung; Male; Middle Aged; Prospective Studies; Recurrence; Remission Induction; Survival Rate; Tretinoin; Weight Gain

1999
Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
    Leukemia, 1999, Volume: 13, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation; Daunorubicin; Drug Screening Assays, Antitumor; Endothelium, Vascular; Female; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Thromboplastin; Tretinoin

1999
[Effectiveness of trans-retinoic acid in the treatment of acute promyelocytic leukemia: initial results of a multicenter study].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:7

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Time Factors; Treatment Outcome; Tretinoin

1999
Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.
    Blood, 2000, Jan-01, Volume: 95, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Female; Fever; Glucocorticoids; Humans; Incidence; Infant; Leukemia, Promyelocytic, Acute; Lung; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Remission Induction; Respiratory Distress Syndrome; Syndrome; Tretinoin; Weight Gain

2000
[Immobilized forms of daunorubicin in patients with acute leukemia].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:10

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Bone Marrow; Cerebrospinal Fluid; Daunorubicin; Drug Carriers; Erythrocytes; Female; Humans; Leukemia, Promyelocytic, Acute; Liposomes; Male; Middle Aged; Neoplasm Recurrence, Local; Remission Induction; Spectrometry, Fluorescence

1999
Molecular analysis and clinical outcome of adult APL patients with the type V PML-RARalpha isoform: results from intergroup protocol 0129.
    Blood, 2000, Jan-15, Volume: 95, Issue:2

    Topics: Adult; Amino Acid Sequence; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Cytarabine; Daunorubicin; Exons; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Prognosis; Protein Isoforms; Remission Induction; Sequence Deletion; Transcription, Genetic; Tretinoin

2000
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia.
    European journal of haematology, 2000, Volume: 64, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Remission Induction; Retrospective Studies; Tretinoin

2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
    British journal of haematology, 2000, Volume: 111, Issue:3

    Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 8; Chromosomes, Human, Pair 9; Cohort Studies; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate; Translocation, Genetic; Tretinoin; Trisomy

2000
Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.
    Haematologica, 2002, Volume: 87, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cuba; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Remission Induction; Survival Rate; Treatment Outcome; Tretinoin

2002
All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.
    Blood, 1992, Nov-01, Volume: 80, Issue:9

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoguazone; Pilot Projects; Time Factors; Treatment Outcome; Tretinoin

1992
A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:9

    Topics: Adolescent; Adult; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Remission Induction; Survival Rate

1991
Idarubicin in acute leukemias: experience of the Italian Cooperative Group GIMEMA.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Leukemia; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prospective Studies; Random Allocation; Remission Induction

1989
Acute promyelocytic leukemia: treatment results during a decade at Memorial Hospital.
    Blood, 1989, Volume: 73, Issue:5

    Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nervous System Neoplasms; Prognosis; Remission Induction; Thioguanine

1989

Other Studies

128 other study(ies) available for daunorubicin and Acute Promyelocytic Leukemia

ArticleYear
Alternate application of all-trans-retinoic acid and arsenic trioxide combined with idarubicin/daunorubicin in treatment of acute promyelocytic leukemia.
    Pakistan journal of pharmaceutical sciences, 2022, Volume: 35, Issue:1

    Topics: Antineoplastic Agents; Arsenic Trioxide; Cohort Studies; Daunorubicin; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Prospective Studies; Tretinoin

2022
Shifting gears to differentiation agents in acute promyelocytic leukemia with resource constraints-a cohort study.
    Acta oncologica (Stockholm, Sweden), 2022, Volume: 61, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Retrospective Studies; Syndrome; Treatment Outcome; Tretinoin

2022
Pathological changes of the myocardium in reworsening of anthracycline-induced cardiomyopathy after explant of a left ventricular assist device.
    Nagoya journal of medical science, 2020, Volume: 82, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cardiotoxicity; Daunorubicin; Device Removal; Disease Progression; Female; Fibrosis; Heart-Assist Devices; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Myocardium; Time Factors; Ventricular Function, Left

2020
Effect of daunorubicin on acute promyelocytic leukemia cells using nuclear magnetic resonance spectroscopy-based metabolomics.
    Environmental toxicology and pharmacology, 2020, Volume: 78

    Topics: Adult; Antineoplastic Agents; Cell Line, Tumor; Daunorubicin; Female; Glucose; Humans; Leukemia, Promyelocytic, Acute; Lipid Metabolism; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Young Adult

2020
Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
    British journal of haematology, 2018, Volume: 181, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biopsy; Cell Cycle; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Female; fms-Like Tyrosine Kinase 3; Genotype; Humans; Immunophenotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Nuclear Proteins; Nucleophosmin

2018
Cutaneous herald: leukaemia cutis as presenting manifestation of relapse in acute promyelocytic leukaemia.
    BMJ case reports, 2018, May-02, Volume: 2018

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biopsy; Consolidation Chemotherapy; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Oxides; Skin; Tretinoin

2018
[Effect of Daunorubicin on Release and Procoagulant Activity of Microparticles Derived from Acute Promyelocytic Leukemia Cells].
    Zhongguo shi yan xue ye xue za zhi, 2018, Volume: 26, Issue:4

    Topics: Bone Marrow; Cell-Derived Microparticles; Daunorubicin; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute

2018
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.
    Cell death & disease, 2013, Feb-28, Volume: 4

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Antibiotics, Antineoplastic; Apoptosis; bcl-Associated Death Protein; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinase Type I; Cyclic AMP-Dependent Protein Kinase Type II; Daunorubicin; Dinoprostone; Disease Progression; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, Inbred NOD; Mice, SCID; RNA Interference; RNA, Small Interfering; Theophylline; Transplantation, Heterologous; Tretinoin

2013
A rare case with typical acute promyelocytic leukemia morphology associated with isolated isochromosome 17q without RARα rearrangement.
    Hematology/oncology and stem cell therapy, 2013, Volume: 6, Issue:1

    Topics: Antibiotics, Antineoplastic; Bone Marrow; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; In Situ Hybridization, Fluorescence; Isochromosomes; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha

2013
All-trans-retinoic acid-induced scrotal ulcers in a patient with acute promyelocytic leukemia.
    Cutis, 2013, Volume: 91, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Eruptions; Humans; Leukemia, Promyelocytic, Acute; Male; Scrotum; Skin Ulcer; Tretinoin

2013
Acute promyelocytic leukemia with Flt3-TKD and WT1 mutations relapsing in a testicle and followed by systemic relapse.
    Acta haematologica, 2013, Volume: 130, Issue:4

    Topics: Adult; Arsenic Trioxide; Arsenicals; Combined Modality Therapy; Daunorubicin; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasm Recurrence, Local; Oxides; Salvage Therapy; Sarcoma, Myeloid; Testicular Neoplasms; Testis; Tretinoin; WT1 Proteins

2013
Long-term efficacy of low-dose all-trans retinoic acid plus minimal chemotherapy induction followed by the addition of intravenous arsenic trioxide post-remission therapy in newly diagnosed acute promyelocytic leukaemia.
    Hematological oncology, 2014, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; China; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Dexamethasone; Drug Evaluation; Female; Harringtonines; Homoharringtonine; Humans; Idarubicin; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Methotrexate; Middle Aged; Neoplasm, Residual; Oncogene Proteins, Fusion; Oxides; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Tretinoin; Young Adult

2014
One acute promyelocytic leukemia patient underwent complete molecular remission with consistent presence of t (2; 3) (p25; q21) karyotype.
    Expert opinion on therapeutic targets, 2013, Volume: 17, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 3; Daunorubicin; Female; fms-Like Tyrosine Kinase 3; Genes, Wilms Tumor; Humans; Induction Chemotherapy; Karyotype; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Remission Induction; Translocation, Genetic; Tretinoin; Young Adult

2013
Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
    Thrombosis research, 2014, Volume: 133, Issue:3

    Topics: Antibiotics, Antineoplastic; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Cell-Derived Microparticles; Daunorubicin; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Microscopy, Electron, Transmission; Thrombophilia; Thromboplastin; Thrombosis; Tumor Cells, Cultured; Venous Thromboembolism

2014
[Pulmonary differentiation -/ATRA syndrome within the scope of therapy of acute promyelocytic leukemia (APL)].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2014, Volume: 186, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Diagnosis, Differential; Dyspnea; Female; Follow-Up Studies; Humans; Induction Chemotherapy; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Pleural Effusion; Pulmonary Edema; Thioguanine; Tomography, X-Ray Computed; Tretinoin

2014
[Acute promyelocytic leukemia: results of the Chilean protocol LPA2000].
    Revista medica de Chile, 2013, Volume: 141, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chile; Daunorubicin; Female; Humans; Induction Chemotherapy; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin; Young Adult

2013
Incorporation of arsenic trioxide in induction therapy improves survival of patients with newly diagnosed acute promyelocytic leukaemia.
    European journal of haematology, 2014, Volume: 93, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Retrospective Studies; Survival Analysis; Tretinoin

2014
Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia
    Annals of hematology, 2014, Volume: 93, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Daunorubicin; Disease-Free Survival; DNA, Neoplasm; Female; fms-Like Tyrosine Kinase 3; Gene Expression Regulation, Leukemic; Hemoglobins; Humans; Idarubicin; Kaplan-Meier Estimate; Latin America; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Tandem Repeat Sequences; Treatment Outcome; Tretinoin; Young Adult

2014
A prospective, observational study of added medium-dose cytosine arabinoside versus As2O3 for elderly patients with acute promyelocytic leukemia.
    Medical oncology (Northwood, London, England), 2014, Volume: 31, Issue:10

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Oxides; Polymerase Chain Reaction; Prospective Studies; Survival Rate; Tretinoin

2014
The antileukemia roles of PP242 alone or in combination with daunorubicin in acute leukemia.
    Anti-cancer drugs, 2015, Volume: 26, Issue:4

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Daunorubicin; Drug Synergism; Eukaryotic Initiation Factor-4E; Humans; Indoles; Leukemia; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Mantle-Cell; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Myeloid Cell Leukemia Sequence 1 Protein; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Purines; Signal Transduction; TOR Serine-Threonine Kinases

2015
The influence of joint application of arsenic trioxide and daunorubicin on primary acute promyelocytic leukaemia cells and apoptosis and blood coagulation of cell strain.
    Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:3 Suppl

    Topics: Adult; Annexin A2; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Blood Coagulation; Cell Line, Tumor; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Thrombomodulin; Thromboplastin; Time Factors; Tumor Cells, Cultured; Young Adult

2015
Chemotherapy impedes in vitro microcirculation and promotes migration of leukemic cells with impact on metastasis.
    Biochemical and biophysical research communications, 2016, Oct-28, Volume: 479, Issue:4

    Topics: Antineoplastic Agents; Biomechanical Phenomena; Biomimetic Materials; Cell Death; Cell Movement; Daunorubicin; Doxorubicin; HL-60 Cells; Humans; In Vitro Techniques; Lab-On-A-Chip Devices; Leukemia, Promyelocytic, Acute; Microcirculation; Neoplasm Metastasis

2016
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
    British journal of pharmacology, 2008, Volume: 155, Issue:1

    Topics: Aldehydes; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Cell Proliferation; Cell Survival; Cytoprotection; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Time Factors

2008
[Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2008, Volume: 10, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Infant; Leukemia, Promyelocytic, Acute; Male; Tretinoin

2008
Chemotherapy induced esophageal stricture.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Down Syndrome; Esophageal Stenosis; Esophagectomy; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Tretinoin

2009
Curative strategies in acute promyelocytic leukemia.
    Hematology. American Society of Hematology. Education Program, 2008

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Clinical Trials as Topic; Cytarabine; Daunorubicin; Disease-Free Survival; Growth Inhibitors; History, 20th Century; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasm Recurrence, Local; Oxides; Tretinoin

2008
Resuscitation of acute anthracycline-induced cardiogenic shock and refractory hypoxemia with mechanical circulatory supports: Pitfalls and strategies.
    Resuscitation, 2009, Volume: 80, Issue:3

    Topics: Adult; Cardiopulmonary Resuscitation; Daunorubicin; Doxorubicin; Fatal Outcome; Female; Follow-Up Studies; Heart-Assist Devices; Humans; Hypoxia; Leukemia, Promyelocytic, Acute; Lymphoma, Follicular; Middle Aged; Shock, Cardiogenic

2009
Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.
    Pediatric blood & cancer, 2010, Volume: 54, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Mercaptopurine; Methotrexate; Oncogene Proteins, Fusion; Radiotherapy; Sarcoma, Myeloid; Tretinoin

2010
Exacerbation of anthracycline-induced early chronic cardiomyopathy with ATRA: role of B-type natriuretic peptide as an indicator of cardiac dysfunction.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:2

    Topics: Adolescent; Antibiotics, Antineoplastic; Cardiomyopathies; Chronic Disease; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Natriuretic Peptide, Brain; Tretinoin

2010
Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia.
    Journal of thrombosis and haemostasis : JTH, 2010, Volume: 8, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation; Blood Coagulation Tests; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Survival; Daunorubicin; Etoposide; Factor Xa; Female; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Male; Membrane Glycoproteins; Microscopy, Confocal; Milk Proteins; Oxides; Phosphatidylserines; Thrombin; Thromboplastin; Tretinoin; Young Adult

2010
Updates on the treatment of acute promyelocytic leukemia.
    Clinical advances in hematology & oncology : H&O, 2010, Volume: 8, Issue:2

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Cytarabine; Daunorubicin; Hemorrhage; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Tetrahydronaphthalenes; Tretinoin

2010
Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?
    American journal of hematology, 2010, Volume: 85, Issue:10

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Colonic Neoplasms; Colonic Polyps; Cytarabine; Daunorubicin; Doxorubicin; Female; Humans; Idarubicin; Indoles; Kidney Neoplasms; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasms, Second Primary; Pyrroles; Remission Induction; Sunitinib; Time Factors; Tretinoin

2010
The role of standard-dose cytarabine in children with acute promyelocytic leukemia: a single-center experience.
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:2

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Treatment Outcome; Tretinoin

2011
Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Middle Aged; Mitomycin; Remission Induction; Renal Dialysis; Tretinoin

2011
Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.
    Leukemia research, 2012, Volume: 36, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Consolidation Chemotherapy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Oxides; Primary Myelofibrosis; Remission Induction; Survivors; Tretinoin

2012
The impact of medical education and networking on the outcome of leukemia treatment in developing countries. The experience of International Consortium on Acute Promyelocytic Leukemia (IC-APL).
    Hematology (Amsterdam, Netherlands), 2012, Volume: 17 Suppl 1

    Topics: Antineoplastic Agents; Bone Marrow; Brazil; Cooperative Behavior; Daunorubicin; Developing Countries; Disease-Free Survival; Education, Medical; Humans; Leukemia, Promyelocytic, Acute; Mexico; Remission Induction; Treatment Outcome; Tretinoin; Uruguay

2012
[Effect of arsenic trioxide and daunorubicin on procoagulant activity of acute promyelocytic leukemia cells].
    Zhonghua yi xue za zhi, 2012, Apr-24, Volume: 92, Issue:16

    Topics: Adult; Arsenic Trioxide; Arsenicals; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Phosphatidylserines; Thromboplastin; Tumor Cells, Cultured; Young Adult

2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Germany; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Leukocyte Count; Maintenance Chemotherapy; Male; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Oxides; Prognosis; Randomized Controlled Trials as Topic; Remission Induction; Risk; Thioguanine; Treatment Outcome; Tretinoin

2013
The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukem
    Experimental hematology, 2002, Volume: 30, Issue:11

    Topics: Antineoplastic Agents; Catalysis; Cell Cycle; Cell Differentiation; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytarabine; Daunorubicin; Deoxycytidine; Diketopiperazines; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Granulocytes; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Neoplasm Proteins; Neoplastic Stem Cells; Piperazines; Razoxane; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; RNA, Messenger; RNA, Neoplasm; Topoisomerase II Inhibitors; Tretinoin; Tumor Cells, Cultured; U937 Cells

2002
[Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Cytarabine; Daunorubicin; Female; Humans; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Remission Induction; Tretinoin

2003
Acute arterial thrombosis in acute promyelocytic leukaemia.
    Clinical and laboratory haematology, 2003, Volume: 25, Issue:4

    Topics: Amputation, Surgical; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cysteine Endopeptidases; Cytarabine; Daunorubicin; Female; Gangrene; Humans; Intermittent Claudication; Ischemia; Leg; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Popliteal Artery; Remission Induction; Smoking; Thioguanine; Thrombophilia; Thromboplastin; Thrombosis; Toes; Tretinoin

2003
Pulmonary embolism and thrombotic thrombocytopenic purpura in acute promyelocytic leukemia treated with all-trans retinoic acid.
    Leukemia & lymphoma, 2003, Volume: 44, Issue:9

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Male; Pulmonary Embolism; Purpura, Thrombotic Thrombocytopenic; Remission Induction; Tretinoin

2003
MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.
    International journal of hematology, 2003, Volume: 78, Issue:5

    Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Cytarabine; Daunorubicin; Enzyme Inhibitors; Etoposide; Fatal Outcome; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Oncogene Proteins, Fusion; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Topoisomerase II Inhibitors; Translocation, Genetic; Tretinoin

2003
Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
    Annals of hematology, 2005, Volume: 84, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Cytarabine; Daunorubicin; Drug Resistance, Neoplasm; Follow-Up Studies; Humans; Leukemia, Promyelocytic, Acute; Male; Neoplasm Proteins; Oncogene Proteins, Fusion; Oxides; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic

2005
A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment.
    Acta medica Okayama, 2004, Volume: 58, Issue:5

    Topics: Adolescent; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Daunorubicin; Epidural Space; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Sarcoma, Myeloid; Spinal Neoplasms; Thoracic Vertebrae

2004
Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Atresia; Child; Child, Preschool; Cytarabine; Daunorubicin; Female; Graft vs Host Disease; Humans; Immunosuppressive Agents; Leukemia, Promyelocytic, Acute; Liver Transplantation; Living Donors; Ornithine Carbamoyltransferase Deficiency Disease; Remission Induction; Tacrolimus; Tretinoin

2005
Pleural tumors as sole primary manifestation of acute promyelocytic leukemia.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Pleural Neoplasms; Tomography, X-Ray Computed

2006
A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells.
    Biochemistry, 2005, Dec-06, Volume: 44, Issue:48

    Topics: Cell Compartmentation; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Lysosomes; Microscopy, Fluorescence

2005
Shifting to outpatient management of acute myeloid leukemia: a prospective experience.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Feasibility Studies; Female; Humans; Inpatients; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Outpatients; Patient Discharge; Patient Readmission; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome

2006
The effect of the structure of branched polypeptide carrier on intracellular delivery of daunomycin.
    Biochimica et biophysica acta, 2006, Volume: 1758, Issue:3

    Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Daunorubicin; Drug Carriers; HL-60 Cells; Humans; Intercellular Signaling Peptides and Proteins; Leukemia L1210; Leukemia, Promyelocytic, Acute; Liposomes; Mice; Molecular Structure; Peptides; Proteins; Tumor Cells, Cultured

2006
Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.
    Molecular cancer therapeutics, 2006, Volume: 5, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Caspase Inhibitors; Caspases; Cytarabine; Cytochromes a; Cytochromes c; Daunorubicin; Down-Regulation; Harringtonines; HL-60 Cells; Homoharringtonine; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proteasome Inhibitors; Protein Biosynthesis; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-bcl-2

2006
Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Cancer genetics and cytogenetics, 2006, Volume: 167, Issue:2

    Topics: Adult; Antineoplastic Agents; Chromosomes, Human, Pair 1; Cytarabine; Daunorubicin; Female; Humans; Isochromosomes; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Myelodysplastic Syndromes

2006
Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brazil; Child; Child, Preschool; Chromosome Inversion; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Leukemic; Genes, Wilms Tumor; Humans; Infant; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Neoplasm Proteins; Prognosis; Proportional Hazards Models; Reverse Transcriptase Polymerase Chain Reaction; Survival Analysis; Translocation, Genetic; WT1 Proteins

2007
Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
    Haematologica, 2006, Volume: 91, Issue:12 Suppl

    Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Computer Systems; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Methotrexate; Neoplasm Proteins; Oncogene Proteins, Fusion; Remission Induction; Reverse Transcriptase Polymerase Chain Reaction; Translocation, Genetic; Tretinoin

2006
Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    British journal of haematology, 2007, Volume: 137, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Oncogene Proteins, Fusion; Remission Induction; Translocation, Genetic; Tretinoin

2007
Impact of FLT3 internal tandem duplications on Indian acute promyelocytic leukemia patients: prognostic implications.
    Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; fms-Like Tyrosine Kinase 3; Follow-Up Studies; Gene Duplication; Humans; India; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Mercaptopurine; Methotrexate; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Prognosis; Remission Induction; Tandem Repeat Sequences; Treatment Outcome; Tretinoin

2007
Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.
    The Malaysian journal of pathology, 2006, Volume: 28, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Primary Myelofibrosis

2006
[Effect of daunorubicin and cytarabine on cell line NB4].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2007, Volume: 28, Issue:4

    Topics: Apoptosis; Cytarabine; Daunorubicin; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute

2007
All-trans retinoic acid syndrome: another cause of drug-induced respiratory failure.
    Southern medical journal, 2007, Volume: 100, Issue:9

    Topics: Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dyspnea; Female; Humans; Leukemia, Promyelocytic, Acute; Respiratory Insufficiency; Tretinoin

2007
Effect of the combination of ATRA, ATO and DNR on CD11b expression in NB4 cells.
    Leukemia research, 2008, Volume: 32, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; CD11b Antigen; Cell Line, Tumor; Daunorubicin; Humans; Leukemia, Promyelocytic, Acute; Oxides; Tretinoin

2008
Nephrotic syndrome developed in a patient with acute promyelocytic leukemia treated with daunomycin.
    Nephron, 1995, Volume: 70, Issue:3

    Topics: Adult; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Nephrotic Syndrome

1995
All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
    Leukemia, 1994, Volume: 8, Issue:12

    Topics: Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Cells; Colony-Forming Units Assay; Cytarabine; Daunorubicin; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Megakaryocytes; Tretinoin

1994
[Intermittent-dose ara-C/daunomycin therapy combined with cyclosporin-A and G-CSF led to a fourth remission in a patient with acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclosporine; Cytarabine; Daunorubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Recurrence; Remission Induction

1995
Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.
    Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:11

    Topics: Apoptosis; Caffeine; Carboplatin; Cluster Analysis; Coloring Agents; Daunorubicin; Drug Resistance, Neoplasm; Flow Cytometry; G2 Phase; Gamma Rays; Gene Expression Regulation, Leukemic; Glutathione; GTP-Binding Proteins; HL-60 Cells; Humans; Immunohistochemistry; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Lymphoma, Non-Hodgkin; Multivariate Analysis; Oncogene Proteins v-fos; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; ras Proteins; S Phase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Tumor Suppressor Protein p53

1995
[Successful adjuvant therapy of M-CSF with chemotherapy of two cases of chemotherapy resistant acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:6

    Topics: Aclarubicin; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Resistance; Female; Humans; Leukemia, Promyelocytic, Acute; Macrophage Colony-Stimulating Factor; Male; Mercaptopurine; Prednisolone; Remission Induction

1995
Rapid progression of 'retinoic acid syndrome' in the hypogranular variant of acute promyelocytic leukaemia, despite treatment with dexamethasone and conventional chemotherapy.
    Clinical and laboratory haematology, 1994, Volume: 16, Issue:4

    Topics: Acute Kidney Injury; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocytosis; Renal Dialysis; Respiration, Artificial; Respiratory Insufficiency; Syndrome; Tretinoin

1994
Acute colonic pseudo-obstruction (Ogilvie's syndrome) during induction treatment with chemotherapy and all-trans-retinoic acid for acute promyelocytic leukemia.
    American journal of hematology, 1995, Volume: 49, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Pseudo-Obstruction; Cytarabine; Daunorubicin; Female; Fever; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Middle Aged; Remission Induction; Tretinoin

1995
History of promyelocytic leukaemia.
    Leukemia, 1994, Volume: 8 Suppl 2

    Topics: Daunorubicin; History, 20th Century; Humans; Leukemia, Promyelocytic, Acute; Remission Induction; Tretinoin

1994
Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Leukemia, 1995, Volume: 9, Issue:2

    Topics: Adult; Aged; Antibodies, Monoclonal; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cell Differentiation; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Idarubicin; Immunologic Factors; Leukemia, Promyelocytic, Acute; Life Tables; Male; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Neutropenia; Nuclear Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Promyelocytic Leukemia Protein; Receptors, Retinoic Acid; Remission Induction; Salvage Therapy; Sialic Acid Binding Ig-like Lectin 3; Survival Analysis; Transcription Factors; Treatment Outcome; Tretinoin; Tumor Suppressor Proteins

1995
The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance.
    Biochemical and biophysical research communications, 1995, Mar-08, Volume: 208, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Base Sequence; Carcinoma, Small Cell; Cell Line; Cell Survival; Clone Cells; Daunorubicin; DNA Primers; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Gene Expression; Humans; Leukemia, Promyelocytic, Acute; Leukotriene Antagonists; Lung Neoplasms; Membrane Proteins; Molecular Sequence Data; Multidrug Resistance-Associated Proteins; Polymerase Chain Reaction; Propionates; Quinolines; Receptors, Immunologic; Receptors, Leukotriene; Tumor Cells, Cultured; Vincristine

1995
Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
    Cytometry, 1994, Sep-01, Volume: 17, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blast Crisis; Child; Child, Preschool; Daunorubicin; Drug Resistance, Multiple; Female; Flow Cytometry; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Salvage Therapy; Treatment Failure; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine

1994
A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
    Leukemia, 1994, Volume: 8, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child, Preschool; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thioguanine; Translocation, Genetic

1994
Effect of differentiating agents on modulation of MDR1 gene expression in multidrug-resistant hematopoietic HL60/DNR cell line.
    Experimental hematology, 1993, Volume: 21, Issue:6

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Daunorubicin; Dimethyl Sulfoxide; Down-Regulation; Drug Resistance; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Leukemia, Promyelocytic, Acute; Membrane Glycoproteins; RNA, Messenger; Tretinoin; Tumor Cells, Cultured

1993
[Acute promyelocytic leukemia (APL) resulting in broad cerebral infarction during all-trans retinoic acid (ATRA) treatment].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1994, Volume: 35, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Infarction; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Tretinoin

1994
[Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Sangre, 1993, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Blood Coagulation Tests; Child, Preschool; Combined Modality Therapy; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Mitoxantrone; Plasma; Platelet Transfusion; Remission Induction; Treatment Outcome

1993
Repeated complete remission in a patient with acute promyelocytic leukemia after treatment with 13-cis-retinoic acid first and with all-trans-retinoic acid in relapse.
    The Clinical investigator, 1993, Volume: 71, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Isotretinoin; Leukemia, Promyelocytic, Acute; Middle Aged; Recurrence; Remission Induction; Tretinoin

1993
[Six cases of therapy related leukemia; case reports and review of the literature].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:10

    Topics: Aclarubicin; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Daunorubicin; Female; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms, Second Primary; Survival Rate

1993
t(15;17) hypergranular acute promyelocytic leukemia (M3) developing into a t(3;6) M3 without t(15;17) at relapse.
    Leukemia & lymphoma, 1995, Volume: 19, Issue:1-2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chromosome Mapping; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 6; Cytarabine; Daunorubicin; Humans; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Polymerase Chain Reaction; Recurrence; Translocation, Genetic; Tretinoin

1995
Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.
    Blood, 1996, Sep-01, Volume: 88, Issue:5

    Topics: Adult; Antineoplastic Agents; Cell Differentiation; Cell Division; Chromosome Aberrations; Cytarabine; Daunorubicin; DNA Mutational Analysis; Drug Resistance, Neoplasm; Fatal Outcome; Female; HL-60 Cells; Humans; Immunophenotyping; Karyotyping; Leukemia, Promyelocytic, Acute; Mercaptopurine; Neoplasm Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prednisolone; Tretinoin; Tumor Cells, Cultured

1996
Acute leukemia during pregnancy: obstetric management and perinatal outcome of two cases.
    European journal of obstetrics, gynecology, and reproductive biology, 1995, Volume: 63, Issue:2

    Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Fatal Outcome; Female; Humans; Leukemia, Promyelocytic, Acute; Mitoxantrone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Recurrence; Thioguanine

1995
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Translocation, Genetic

1997
Extramedullary acute promyelocytic leukemia.
    Cancer, 1997, Jun-01, Volume: 79, Issue:11

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Colon; Daunorubicin; Fatal Outcome; Humans; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Male; Neoplasm Recurrence, Local; Tretinoin

1997
Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:7

    Topics: Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Combined Modality Therapy; Cytarabine; Daunorubicin; Ear Canal; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Mercaptopurine; Middle Aged; Mitoxantrone; Neoplasm Proteins; Oncogene Proteins, Fusion; Radiotherapy; Recurrence; Remission Induction; Salvage Therapy; Tretinoin; Vindesine

1997
[Successful treatment of subdural hematoma with operation in a patient with acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1997, Volume: 38, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Hematoma, Subdural; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tretinoin

1997
Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid.
    Experimental hematology, 1997, Volume: 25, Issue:12

    Topics: Adenosine; Adenosylhomocysteinase; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Cycle; Cell Differentiation; Cytarabine; Daunorubicin; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; Granulocytes; Humans; Hydrolases; Leukemia, Promyelocytic, Acute; Leukopoiesis; Tretinoin; Tumor Cells, Cultured

1997
Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Prognosis; Prospective Studies; Treatment Outcome; Tretinoin

1998
[Consolidation therapy with high-dose cytarabine and daunorubicin for prolonged disease free survival in acute myelocytic leukemia].
    Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged

1996
Influence of increased body mass index on drug toxicity in patients with acute promyelocytic leukemia.
    Leukemia, 1998, Volume: 12, Issue:9

    Topics: Adult; Aged; Amsacrine; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cytarabine; Daunorubicin; Female; Heart; Heart Failure; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Tretinoin

1998
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases.
    Cancer, 1998, Oct-15, Volume: 83, Issue:8

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Cytarabine; Daunorubicin; Disease Progression; Fatal Outcome; Female; Gene Amplification; Gene Rearrangement; Humans; Idarubicin; Immunophenotyping; Leukemia, Promyelocytic, Acute; Lymph Nodes; Male; Middle Aged; Neoplasm Recurrence, Local; Polymerase Chain Reaction; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Skin Neoplasms; Translocation, Genetic; Tretinoin

1998
Management of acute promyelocytic leukemia relapse in the ATRA era.
    Haematologica, 1998, Volume: 83, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Therapy; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Recurrence; Remission Induction; Salvage Therapy; Thioguanine; Treatment Outcome; Tretinoin

1998
Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
    Leukemia, 1999, Volume: 13, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Polycythemia Vera; Preleukemia; Prognosis; Remission Induction; Thrombocythemia, Essential; Thrombophilia; Translocation, Genetic; Tretinoin

1999
[Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia].
    Terapevticheskii arkhiv, 1999, Volume: 71, Issue:7

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Liposomes; Recurrence; Time Factors; Tretinoin

1999
[Central nervous system relapse with multiple brain masses in an acute promyelocytic leukemia patient treated with all-trans retinoic acid].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1999, Volume: 40, Issue:10

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Central Nervous System Neoplasms; Cytarabine; Daunorubicin; Female; Humans; Injections, Spinal; Leukemia, Promyelocytic, Acute; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome; Tretinoin

1999
Induction of apoptosis by idarubicin: how important is the plasma peak?
    International journal of clinical pharmacology and therapeutics, 2000, Volume: 38, Issue:4

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Area Under Curve; Daunorubicin; DNA, Neoplasm; HL-60 Cells; Humans; Idarubicin; Leukemia, Promyelocytic, Acute

2000
P-glycoprotein (PGP), lung resistance-related protein (LRP) and multidrug resistance-associated protein (MRP) expression in acute promyelocytic leukaemia.
    British journal of haematology, 2000, Volume: 108, Issue:4

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Daunorubicin; Drug Resistance, Multiple; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Recurrence; Tumor Cells, Cultured; Vault Ribonucleoprotein Particles

2000
Interferon may reduce minimal residual disease of acute promyelocytic leukemia.
    Leukemia, 2000, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Idarubicin; Interferons; Leukemia, Promyelocytic, Acute; Neoplasm, Residual; Recurrence; Remission Induction; Tretinoin

2000
Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA--a manifestation of the basic disease or the treatment.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:5-6

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Coagulation Tests; Cytarabine; Daunorubicin; Dyspnea; Fatal Outcome; Fever; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Lung Diseases; Male; Middle Aged; Pulmonary Alveoli; Remission Induction; Syndrome; Tretinoin

2000
Avascular necrosis of head of femur in a patient with acute promyelocytic leukemia.
    Leukemia & lymphoma, 2000, Volume: 37, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dexamethasone; Femur Head Necrosis; Humans; Leukemia, Promyelocytic, Acute; Male; Tretinoin

2000
[Acute myeloid leukemia in the adult. Results of the National Antineoplastic Drug Protocol at the Hospital del Salvador, 1990-1998].
    Revista medica de Chile, 2000, Volume: 128, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Idarubicin; Immunophenotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Retrospective Studies; Treatment Outcome

2000
Treatment of acute promyelocytic leukaemia using a combination of all-trans retinoic acid and chemotherapy.
    Annals of the Academy of Medicine, Singapore, 2001, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Daunorubicin; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methotrexate; Middle Aged; Tretinoin

2001
[Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 1999, Volume: 20, Issue:9

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Daunorubicin; Factor VIII; Humans; Leukemia, Promyelocytic, Acute; Oxides; RNA, Messenger; Thromboplastin; Tretinoin; Tumor Cells, Cultured

1999
Acute arterial occlusion as the presenting feature in acute promyelocytic leukaemia.
    British journal of haematology, 2001, Volume: 115, Issue:1

    Topics: Amputation, Surgical; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Arterial Occlusive Diseases; Cytarabine; Daunorubicin; Female; Foot Diseases; Heparin; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Necrosis; Popliteal Artery; Thioguanine; Tretinoin

2001
Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia.
    European journal of haematology, 2001, Volume: 67, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cytarabine; Daunorubicin; Female; Humans; Hyperplasia; Leukemia, Promyelocytic, Acute; Pseudotumor Cerebri; Radiography; Sweet Syndrome; Thymus Gland; Tretinoin

2001
Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.
    Journal of pediatric hematology/oncology, 2001, Volume: 23, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cerebral Infarction; Child; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Humans; Hypertension; Kidney Failure, Chronic; Leukemia, Promyelocytic, Acute; Male; Neoplasms, Second Primary; Obesity; Remission Induction; Thioguanine

2001
Patchy polyneuropathy in acute promyelocytic leukaemia.
    Clinical and laboratory haematology, 1992, Volume: 14, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Combined Modality Therapy; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Male; Paraneoplastic Syndromes; Peripheral Nervous System Diseases; Remission Induction; Translocation, Genetic; Transplantation, Homologous

1992
[Auer rods-positive neutrophils observed at diagnosis increased after remission induction in patient with acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Cytarabine; Daunorubicin; Humans; Inclusion Bodies; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Neutrophils; Prednisolone; Remission Induction

1992
Abnormal chloride conductance in multidrug resistant HL60/AR cells.
    Cancer letters, 1992, Sep-14, Volume: 66, Issue:1

    Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Cell Membrane Permeability; Chloride Channels; Chlorides; Cyclic AMP; Daunorubicin; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Hydrogen-Ion Concentration; Intracellular Fluid; Leukemia, Promyelocytic, Acute; Membrane Proteins; Tumor Cells, Cultured

1992
Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry.
    Cytometry, 1992, Volume: 13, Issue:8

    Topics: Benzimidazoles; Daunorubicin; DNA; Energy Transfer; Flow Cytometry; Fluorescence; Humans; Idarubicin; Intercalating Agents; Leukemia, Promyelocytic, Acute; Tumor Cells, Cultured

1992
[Two cases of acute promyelocytic leukemia in pregnancy and the effect of anthracyclines on fetal development].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Embryonic and Fetal Development; Female; Fetal Death; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Prednisolone; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Complications, Neoplastic

1992
[A case report of an acute promyelocytic leukemia patient showing remarkable thrombopoiesis prior to granulopoiesis by hM-CSF treatment after chemotherapy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Granulocytes; Hematopoiesis; Humans; Leukemia, Promyelocytic, Acute; Macrophage Colony-Stimulating Factor; Male; Middle Aged; Mitoxantrone

1992
Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis.
    Blood, 1992, Apr-15, Volume: 79, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Bone Marrow; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Cytarabine; Daunorubicin; DNA, Neoplasm; Etoposide; Female; Genetic Linkage; Humans; Leukemia, Promyelocytic, Acute; Translocation, Genetic; Tretinoin; X Chromosome

1992
Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
    Cancer research, 1992, Jun-01, Volume: 52, Issue:11

    Topics: Biological Transport; Cell Line; Cell Membrane; Cell Nucleus; Cytosol; Daunorubicin; Doxorubicin; Drug Resistance; Humans; Kinetics; Leukemia, Promyelocytic, Acute; Microscopy, Fluorescence; Monensin; Nigericin

1992
[A successful allogeneic bone marrow transplantation for acute promyelocytic leukemia with anthracycline-induced cardiomyopathy at relapse].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1992, Volume: 33, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cardiomyopathies; Combined Modality Therapy; Daunorubicin; Female; Hemodynamics; Humans; Leukemia, Promyelocytic, Acute; Recurrence; Transplantation, Homologous

1992
Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60.
    Cancer research, 1992, Jul-01, Volume: 52, Issue:13

    Topics: Cell Differentiation; Daunorubicin; Doxorubicin; Humans; Leukemia; Leukemia, Promyelocytic, Acute; Protein Kinase C; Sphingosine; Tumor Cells, Cultured

1992
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
    Cancer research, 1991, Feb-15, Volume: 51, Issue:4

    Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured

1991
Use of plasma cytotoxic activity to model cytotoxic pharmacodynamics of anticancer drugs.
    Cancer chemotherapy and pharmacology, 1991, Volume: 29, Issue:2

    Topics: Adult; Aged; Cytarabine; Daunorubicin; Deoxycytidine; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Tumor Cells, Cultured

1991
[Focal hepato-splenic mycosis caused by Trichosporon beigelii in a patient with acute leukemia].
    Sangre, 1991, Volume: 36, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Disease Susceptibility; Hepatitis; Humans; Immunocompromised Host; Leukemia, Promyelocytic, Acute; Male; Mycoses; Opportunistic Infections; Splenic Diseases; Trichosporon

1991
Response to trans-retinoic acid in an AMLM3 patient resistant to cis-retinoic acid.
    Leukemia research, 1991, Volume: 15, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Humans; Leukemia, Promyelocytic, Acute; Lomustine; Male; Middle Aged; Stereoisomerism; Tretinoin

1991
The role of the phorbol ester receptor/protein kinase C in the sensitivity of leukemic cells to anthracyclines.
    Cancer communications, 1991, Volume: 3, Issue:3

    Topics: Antibiotics, Antineoplastic; Caenorhabditis elegans Proteins; Carrier Proteins; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Leukemia, Promyelocytic, Acute; Phorbol 12,13-Dibutyrate; Protein Kinase C; Receptors, Drug; Tumor Cells, Cultured; Up-Regulation

1991
Potentiation of doxorubicin cytotoxicity by (+)-1,2-bis-(3,5-dioxopiperazinyl-1-yl) propane (ICRF-187) in human leukemic HL-60 cells.
    Cancer communications, 1990, Volume: 2, Issue:4

    Topics: Biological Transport; Cell Line; Cell Survival; Daunorubicin; Doxorubicin; Drug Synergism; Electron Spin Resonance Spectroscopy; Humans; Leukemia, Promyelocytic, Acute; Piperazines; Razoxane; Stereoisomerism; Tumor Cells, Cultured

1990
Acquired alpha-2-antiplasmin deficiency in acute promyelocytic leukaemia.
    British journal of haematology, 1988, Volume: 70, Issue:1

    Topics: alpha-2-Antiplasmin; Blood Coagulation; Daunorubicin; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Prospective Studies

1988
Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.
    American journal of hematology, 1989, Volume: 32, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Demyelinating Diseases; Horner Syndrome; Humans; Leukemia, Promyelocytic, Acute; Male; Peripheral Nervous System Diseases

1989
[Methicillin-resistant staphylococcal enterocolitis developed after induction chemotherapy in a case of acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enterocolitis; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Methicillin; Middle Aged; Penicillin Resistance; Prednisolone; Remission Induction; Staphylococcal Infections; Staphylococcus aureus

1989
[Relapse of gingival tumor during hematological remission in acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:11

    Topics: Aclarubicin; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Etoposide; Gingival Neoplasms; Humans; Leukemia, Promyelocytic, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone; Recurrence; Remission Induction; Vinblastine; Vincristine

1989
[4'-(9-acridinylamino)-methanesulfon-m-aniside (AMSA) combination salvage therapy in refractory acute non-lymphocytic leukemia in adults].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Aged; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Drug Evaluation; Drug Resistance; Female; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Leukopenia; Male; Middle Aged; Prednisolone; Remission Induction; Thioguanine; Thrombocytopenia

1989
[Successful treatment by a drainage of subdural hematoma in a case of intracranial hemorrhage due to DIC complicated with acute promyelocytic leukemia].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebral Hemorrhage; Cytarabine; Daunorubicin; Disseminated Intravascular Coagulation; Drainage; Female; Hematoma, Subdural; Humans; Leukemia, Promyelocytic, Acute; Mercaptopurine; Prednisolone; Remission Induction

1989
Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
    Cancer biochemistry biophysics, 1988, Volume: 10, Issue:1

    Topics: Aclarubicin; Antibiotics, Antineoplastic; Biological Transport; Cell Differentiation; Cell Division; Cell Line; Daunorubicin; DNA, Neoplasm; Doxorubicin; Humans; Kinetics; Leukemia, Promyelocytic, Acute

1988
Synergistic antiproliferative effects on HL-60 cells: deferoxamine enhances cytosine arabinoside, methotrexate, and daunorubicin cytotoxicity.
    The American journal of pediatric hematology/oncology, 1988,Winter, Volume: 10, Issue:4

    Topics: Antimetabolites, Antineoplastic; Cell Line; Cytarabine; Daunorubicin; Deferoxamine; Dose-Response Relationship, Drug; Drug Synergism; Humans; Leukemia, Promyelocytic, Acute; Methotrexate; Tumor Cells, Cultured

1988